Safety and efficacy of antihyperglycaemic agents in diabetic kidney disease

Diabetic kidney disease (DKD) is the major contributor to the mortality and the financial burden of diabetes, accounting for approximately 50% of the cases of end‐stage renal disease (ESRD) in the developed world. Several studies have already demonstrated that achieving blood pressure targets in DKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Niezen, Sebastian, Diaz del Castillo, Humberto, Mendez Castaner, Lumen A., Fornoni, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613230/
https://www.ncbi.nlm.nih.gov/pubmed/31294086
http://dx.doi.org/10.1002/edm2.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613230/
https://www.ncbi.nlm.nih.gov/pubmed/31294086
http://dx.doi.org/10.1002/edm2.72

Ejemplares similares